13F HOLDINGS REPORT
Casdin Capital, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000919574-24-003198
Total Value
$1.35B
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMDW | 5,617,599 | $181.1M | 13.46% |
| 2 | STANDARD BIOTOOLS INC | LAB | 61,907,605 | $167.8M | 12.47% |
| 3 | BIOLIFE SOLUTIONS INC | BLFS | 8,707,165 | $161.5M | 12.01% |
| 4 | SAREPTA THERAPEUTICS INC | SRPT | 1,069,000 | $138.4M | 10.29% |
| 5 | RELAY THERAPEUTICS INC | RLAY | 7,423,574 | $61.6M | 4.58% |
| 6 | ALNYLAM PHARMACEUTICALS INC | ALNY | 358,000 | $53.5M | 3.98% |
| 7 | AVIDITY BIOSCIENCES INC | 05370A108 | 2,084,841 | $53.2M | 3.96% |
| 8 | INTELLIA THERAPEUTICS INC | NTLA | 1,875,000 | $51.6M | 3.83% |
| 9 | STRUCTURE THERAPEUTICS INC | GPCR | 1,116,867 | $47.9M | 3.56% |
| 10 | EXACT SCIENCES CORP | 30063P105 | 650,000 | $44.9M | 3.34% |
| 11 | VERVE THERAPEUTICS INC | 92539P101 | 3,059,094 | $40.6M | 3.02% |
| 12 | TENAYA THERAPEUTICS INC | TNYA | 6,732,971 | $35.2M | 2.62% |
| 13 | ILLUMINA INC | ILMN | 248,000 | $34.1M | 2.53% |
| 14 | BLUEPRINT MEDICINES CORP | 09627Y109 | 326,378 | $31.0M | 2.30% |
| 15 | GENEDX HOLDINGS CORP | WGSWW | 3,136,411 | $28.6M | 2.13% |
| 16 | NEUROGENE INC | NGNE | 524,616 | $26.7M | 1.99% |
| 17 | DENALI THERAPEUTICS INC | DNLI | 1,300,000 | $26.7M | 1.98% |
| 18 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 800,000 | $25.5M | 1.89% |
| 19 | BEAM THERAPEUTICS INC | BEAM | 675,000 | $22.3M | 1.66% |
| 20 | VERACYTE INC | VCYT | 857,904 | $19.0M | 1.41% |
| 21 | PLIANT THERAPEUTICS INC | PLRX | 1,000,000 | $14.9M | 1.11% |
| 22 | CENTURY THERAPEUTICS INC | IPSC | 3,206,380 | $13.4M | 1.00% |
| 23 | 2SEVENTY BIO INC | 901384107 | 2,000,000 | $10.7M | 0.80% |
| 24 | ABCELLERA BIOLOGICS INC | ABCL | 2,360,129 | $10.7M | 0.79% |
| 25 | TANGO THERAPEUTICS INC | TNGX | 1,188,349 | $9.4M | 0.70% |
| 26 | CODEXIS INC | CDXS | 2,000,000 | $7.0M | 0.52% |
| 27 | ABSCI CORPORATION | ABSI | 973,260 | $5.5M | 0.41% |
| 28 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 1,035,859 | $3.9M | 0.29% |
| 29 | KYVERNA THERAPEUTICS INC | KYTX | 150,000 | $3.7M | 0.28% |
| 30 | MONTE ROSA THERAPEUTICS INC | GLUE | 510,882 | $3.6M | 0.27% |
| 31 | SYNDAX PHARMACEUTICALS INC | SNDX | 150,000 | $3.6M | 0.27% |
| 32 | PRIME MEDICINE INC | PRME | 367,175 | $2.6M | 0.19% |
| 33 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 1,459,747 | $1.7M | 0.13% |
| 34 | INTELLIA THERAPEUTICS INC | NTLA | 50,000 | $1.4M | 0.10% |
| 35 | EXSCIENTIA PLC | 30223G102 | 213,900 | $1.2M | 0.09% |
| 36 | SINGULAR GENOMICS SYSTEMS IN | 82933R100 | 1,323,885 | $680,742 | 0.05% |
| 37 | KRONOS BIO INC | 50107A104 | 123,839 | $160,991 | 0.01% |